For America’s politicians, there are few easier bogeymen to rail against than pharma bosses. Only a fifth of the country has a positive opinion of the industry, according to Gallup, a pollster—meaning its executives rank below even estate agents in the public’s esteem. The eye-watering prices of many drugs in America have created the impression of a greedy industry that exploits the sick.